Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
On October 6, 2026, Quest Diagnostics announced that Catherine T. Doherty will retire in July 2027. Effective November 1, 2026, she will transition to a new role as Executive Vice President with responsibilities including health systems, the company's joint venture with Corewell Health, and Project Nova, its multi-year project to modernize its order-to-cash business processes and related technology. Her base salary and annual incentive target are unchanged.
Calendar quarter Q2 2026Earnings call Jul 23, 2026 · most recent call
DGX’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Quest Diagnostics’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: DGX daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $2.62B | +14.6% | $1.95 | +14.7% | 32.7% | 13.8% | 8.5% | $341M |
| FY2025 Q1 | $2.65B | +12.1% | $1.94 | +12.8% | 32.5% | 13.0% | 8.3% | $197M |
| FY2025 Q2 | $2.76B | +15.2% | $2.47 | +21.1% | 34.2% | 15.9% | 10.2% | $436M |
| FY2025 Q3 | $2.82B | +13.2% | $2.16 | +8.5% | 33.7% | 13.7% | 8.7% | $419M |
| FY2025 Q4 | $2.81B | +7.1% | $2.18 | +11.8% | 32.6% | 13.9% | 8.7% | $307M |
| FY2026 Q1 | $2.90B | +9.2% | $2.24 | +15.5% | 32.5% | 13.8% | 8.7% | $164M |
| FY2026 Q2Selected | $3.04B | +10.2% | $2.84 | +15.0% | 33.7% | 15.1% | 10.5% | $330M |
Management-stated figures from DGX’s newest call are part of Tellvest Pro.